JP2023537474A - 疼痛制御のための関節内コルチコステロイドの医薬組成物 - Google Patents

疼痛制御のための関節内コルチコステロイドの医薬組成物 Download PDF

Info

Publication number
JP2023537474A
JP2023537474A JP2023507244A JP2023507244A JP2023537474A JP 2023537474 A JP2023537474 A JP 2023537474A JP 2023507244 A JP2023507244 A JP 2023507244A JP 2023507244 A JP2023507244 A JP 2023507244A JP 2023537474 A JP2023537474 A JP 2023537474A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
use according
intra
pain
grade
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023507244A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023537474A5 (enExample
Inventor
シェウ－ファン シー
カール オスカー ブラウン
Original Assignee
ティーエルシー バイオファーマシューティカルズ、インク．
タイワン リポソーム カンパニー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ティーエルシー バイオファーマシューティカルズ、インク．, タイワン リポソーム カンパニー リミテッド filed Critical ティーエルシー バイオファーマシューティカルズ、インク．
Publication of JP2023537474A publication Critical patent/JP2023537474A/ja
Publication of JP2023537474A5 publication Critical patent/JP2023537474A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2023507244A 2020-08-05 2021-08-05 疼痛制御のための関節内コルチコステロイドの医薬組成物 Pending JP2023537474A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063061395P 2020-08-05 2020-08-05
US63/061,395 2020-08-05
PCT/US2021/044619 WO2022031898A1 (en) 2020-08-05 2021-08-05 Pharmaceutical composition of intra-articular corticosteroid for pain control

Publications (2)

Publication Number Publication Date
JP2023537474A true JP2023537474A (ja) 2023-09-01
JP2023537474A5 JP2023537474A5 (enExample) 2024-07-09

Family

ID=77519828

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507244A Pending JP2023537474A (ja) 2020-08-05 2021-08-05 疼痛制御のための関節内コルチコステロイドの医薬組成物

Country Status (14)

Country Link
US (1) US12514820B2 (enExample)
EP (1) EP4192426A1 (enExample)
JP (1) JP2023537474A (enExample)
KR (1) KR20230048066A (enExample)
CN (1) CN116348093A (enExample)
AU (1) AU2021320774A1 (enExample)
BR (1) BR112023001926A2 (enExample)
CA (1) CA3187955A1 (enExample)
CL (1) CL2023000315A1 (enExample)
IL (1) IL300354A (enExample)
MX (1) MX2023001410A (enExample)
TW (1) TW202220668A (enExample)
WO (1) WO2022031898A1 (enExample)
ZA (1) ZA202301377B (enExample)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020056399A1 (en) * 2018-09-16 2020-03-19 Tlc Biopharmaceuticals, Inc. Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956600B2 (en) * 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
BR112015000174A2 (pt) * 2012-07-05 2017-06-27 Taiwan Liposome Co Ltd método para o tratamento da artrite
EP4389218A3 (en) * 2017-03-14 2024-10-16 Seikagaku Corporation Composition for treating joint disease and kit containing same
EP3820479B1 (en) * 2018-07-09 2026-03-11 Taiwan Liposome Co., Ltd. Methods to reduce complications of intra-articular steroid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020056399A1 (en) * 2018-09-16 2020-03-19 Tlc Biopharmaceuticals, Inc. Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain

Also Published As

Publication number Publication date
BR112023001926A2 (pt) 2023-03-07
AU2021320774A1 (en) 2023-03-09
EP4192426A1 (en) 2023-06-14
MX2023001410A (es) 2023-03-06
US12514820B2 (en) 2026-01-06
ZA202301377B (en) 2026-05-27
CA3187955A1 (en) 2022-02-10
TW202220668A (zh) 2022-06-01
CL2023000315A1 (es) 2023-09-22
KR20230048066A (ko) 2023-04-10
CN116348093A (zh) 2023-06-27
US20230285293A1 (en) 2023-09-14
IL300354A (en) 2023-04-01
WO2022031898A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
JP6535281B2 (ja) 関節炎の処置方法
TWI857961B (zh) 減少關節內類固醇的併發症之方法
TWI843751B (zh) 適用於關節遞送的藥學組成物及其在治療關節疼痛上的用途
US12514820B2 (en) Pharmaceutical composition of intra-articular corticosteroid for pain control
RU2806023C2 (ru) Способы уменьшения осложнений от внутрисуставного стероида
HK40087158A (en) Pharmaceutical composition of intra-articular corticosteroid for pain control
TW202519194A (zh) 用於疼痛控制之關節內皮質類固醇的微脂體組成物
HK40041739A (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
HK40041258A (en) Methods to reduce complications of intra-articular steroid

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240628

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240628

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20251104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260210